Market revenue in 2022 | USD 306.8 million |
Market revenue in 2030 | USD 483.4 million |
Growth rate | 5.8% (CAGR from 2022 to 2030) |
Largest segment | Needle-free injectors |
Fastest growing segment | Pen injectors |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Needle-free injectors, Wearable injectors, Pen injectors, Auto injectors |
Key market players worldwide | Ypsomed Holding AG, BD, Gerresheimer AG ADR, Antares Vision SpA, NuGen Medical Devices Inc, Pfizer Inc, Amgen Inc, Sulzer AG, Owen Mumford, SHL Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to self-injection devices market will help companies and investors design strategic landscapes.
Needle-free injectors was the largest segment with a revenue share of 29.43% in 2023. Horizon Databook has segmented the Middle East & Africa self-injection devices market based on needle-free injectors, wearable injectors, pen injectors, auto injectors covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa self-injection devices market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa self-injection devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account